Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients.
Esteban MJ, Font C, Hernández-Rodríguez J, Valls-Solé J, Sanmartí R, Cardellach F, García-Martínez A, Campo E, Urbano-Márquez A, Grau JM, Cid MC. Esteban MJ, et al. Arthritis Rheum. 2001 Jun;44(6):1387-95. doi: 10.1002/1529-0131(200106)44:6<1387::AID-ART232>3.0.CO;2-B. Arthritis Rheum. 2001. PMID: 11407699 Free article.
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis.
Hernández-Rodríguez J, García-Martínez A, Casademont J, Filella X, Esteban MJ, López-Soto A, Fernández-Solà J, Urbano-Márquez A, Grau JM, Cid MC. Hernández-Rodríguez J, et al. Arthritis Rheum. 2002 Feb;47(1):29-35. doi: 10.1002/art1.10161. Arthritis Rheum. 2002. PMID: 11932875 Free article.
Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
Hernández-Rodríguez J, Segarra M, Vilardell C, Sánchez M, García-Martínez A, Esteban MJ, Grau JM, Urbano-Márquez A, Colomer D, Kleinman HK, Cid MC. Hernández-Rodríguez J, et al. Circulation. 2003 May 20;107(19):2428-34. doi: 10.1161/01.CIR.0000066907.83923.32. Epub 2003 May 12. Circulation. 2003. PMID: 12742994 Clinical Trial.
Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.
Hernández-Rodríguez J, Segarra M, Vilardell C, Sánchez M, García-Martínez A, Esteban MJ, Queralt C, Grau JM, Urbano-Márquez A, Palacín A, Colomer D, Cid MC. Hernández-Rodríguez J, et al. Rheumatology (Oxford). 2004 Mar;43(3):294-301. doi: 10.1093/rheumatology/keh058. Epub 2003 Dec 16. Rheumatology (Oxford). 2004. PMID: 14679293
Gelatinase expression and proteolytic activity in giant-cell arteritis.
Segarra M, García-Martínez A, Sánchez M, Hernández-Rodríguez J, Lozano E, Grau JM, Cid MC. Segarra M, et al. Ann Rheum Dis. 2007 Nov;66(11):1429-35. doi: 10.1136/ard.2006.068148. Epub 2007 May 14. Ann Rheum Dis. 2007. PMID: 17502363 Free PMC article.
218 results